Gilead Sciences, INC. — 13F Holdings

2026 Q3  ·  5 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, GILEAD SCIENCES, INC. maintained a portfolio of 5 distinct positions.
Position History hover any row below to update
Loading…
GILEAD SCIENCES, INC. Foster City, CA Corporate / Strategic Investor AUM $1,464M
PCA Score Concentration Risk
Risk ENB
Total Positions
5
Quarter
2026 Q3
Top Holding
RCUS (55.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-5 of 5

GILEAD SCIENCES, INC. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
RCUS
Arcus Bioscienc...
Healthcare 55.45% 58.76% #1
Prev: #1
7.0
—
no change no change
P
S
31,424,760 $811,701,551 2024 Q4 13F Filing 2026-09-30 2026-11-06
GLPG
Lakefront Bioth...
Healthcare 34.24% 30.34% #2
Prev: #2
6.5
—
no change no change
P
S
16,707,477 $501,284,604 2024 Q4 13F Filing 2026-09-30 2026-11-06
ASMB
Assembly Biosci...
Healthcare 7.99% 8.30% #3
Prev: #3
5.2
—
no change no change
P
S
4,977,089 $116,911,821 2024 Q4 13F Filing 2026-09-30 2026-11-06
KYTX
Kyverna Therape...
Healthcare 1.92% 2.23% #4
Prev: #4
2.3
—
no change no change
P
S
4,126,119 $28,057,609 2024 Q4 13F Filing 2026-09-30 2026-11-06
XLO
Xilio Therapeut...
Healthcare 0.40% 0.38% #5
Prev: #5
1.7
—
no change no change
P
S
650,389 $5,886,020 2024 Q4 13F Filing 2026-09-30 2026-11-06
Showing 1-5 of 5 holdings

Unlock Full GILEAD SCIENCES, INC. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →